Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies (Q37427004)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 July 2013

Language	Label	Description	Also known as
English	Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies	scientific article published on 24 July 2013

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

0 references

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies (English)

1 reference

Europe PubMed Central

20 August 2017

atrial fibrillation

0 references

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Vic Hasselblad

1 reference

Europe PubMed Central

20 August 2017

Jonathan P Piccini

8

object named as

Jonathan P Piccini

1 reference

Europe PubMed Central

20 August 2017

James P Daubert

7

object named as

James P Daubert

1 reference

Europe PubMed Central

20 August 2017

John H. Alexander

6

object named as

John H Alexander

1 reference

Europe PubMed Central

20 August 2017

Tristram D Bahnson

4

object named as

Tristram D Bahnson

1 reference

Europe PubMed Central

20 August 2017

Brett D Atwater

3

object named as

Brett D Atwater

1 reference

Europe PubMed Central

20 August 2017

author name string

Benjamin A Steinberg

1

1 reference

Europe PubMed Central

20 August 2017

Jeffrey B Washam

5

1 reference

Europe PubMed Central

20 August 2017

publication date

24 July 2013

1 reference

Europe PubMed Central

20 August 2017

Journal of Interventional Cardiac Electrophysiology

1 reference

Europe PubMed Central

20 August 2017

37

1 reference

Europe PubMed Central

20 August 2017

3

1 reference

Europe PubMed Central

20 August 2017

213-221

1 reference

Europe PubMed Central

20 August 2017

https://scigraph.springernature.com/pub.10.1007/s10840-013-9813-7

0 references

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

23 August 2017

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

23 August 2017

Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

23 August 2017

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

23 August 2017

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

23 August 2017

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

23 August 2017

Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

23 August 2017

Venice Chart international consensus document on atrial fibrillation ablation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

23 August 2017

A survey of current problems in meta-analysis. Discussion from the Agency for Health Care Policy and Research inter-PORT Work Group on Literature Review/Meta-Analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

14 September 2017

Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

2 September 2018

Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

2 September 2018

Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

2 September 2018

A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

2 September 2018

Factors influencing doctors' selection of dabigatran in non-valvular atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

2 September 2018

Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

2 September 2018

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

2 September 2018

The use of dabigatran immediately after atrial fibrillation ablation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

2 September 2018

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878716

2 September 2018

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9813-7

21 January 2018

A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of bleeding complications post-ablation between warfarin and dabigatran

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10840-013-9813-7

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37427004&oldid=2168028589"